Cost of developmental delay from prenatal exposure to airborne polycyclic aromatic hydrocarbons

Katherine Weiland1, Matthew Neidell, Virginia Rauh

  • 1Department of Health Policy and Management, Columbia University Mailman School of Public Health, New York, NY 10025, USA. kjweiland@gmail.com

Insights

Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) is linked to developmental delays in children. This study estimates the annual cost of special education services for low-income New York City children due to PAH exposure exceeds $13.7 million.

Area of Science:

  • Environmental Health
  • Developmental Pediatrics
  • Public Health Economics

Background:

  • Early life exposure to ambient polycyclic aromatic hydrocarbons (PAHs) is a known risk factor for developmental delays.
  • The economic burden of developmental delays attributed to PAH exposure has not been previously quantified.
  • Previous research identified significant effects of prenatal PAH exposure on mental development in a New York City (NYC) cohort.

Purpose of the Study:

  • To estimate the annual costs of preschool special education services for low-income NYC children experiencing developmental delays linked to prenatal PAH exposure.
  • To provide economic data supporting public health policies aimed at reducing ambient PAH levels.

Main Methods:

  • Utilized data from a cohort of low-income women and children in NYC.
  • Applied the Environmentally Attributable Fraction (EAF) method to estimate costs.
  • Focused on costs associated with preschool special education services for children with developmental delay.

Main Results:

  • The estimated annual cost of PAH-exposure-related special education services for Medicaid births in NYC is over $13.7 million.
  • This significant economic impact highlights the societal cost of developmental delays from environmental exposures.
  • The findings underscore the financial benefits of mitigating PAH exposure.

Conclusions:

  • Prenatal exposure to ambient PAHs incurs substantial economic costs for special education services in NYC.
  • Reducing PAH levels in NYC air is a cost-effective public health strategy.
  • Policy interventions targeting PAH reduction are warranted to mitigate developmental delays and associated economic burdens.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...